Drug-target interactions: only the first step in the commitment to a programmed cell death?
1991
Understanding How Cancer Drugs Induce Cell Death
publication
Evidence: moderate
Author Information
Author(s): C. Dive, J.A. Hickman
Primary Institution: Aston University and The University of Manchester
Hypothesis
The response of cancer cells to drug-target interactions may determine the effectiveness of chemotherapy.
Conclusion
The study suggests that the ability of cancer cells to undergo programmed cell death is crucial for the success of chemotherapy.
Supporting Evidence
- The review discusses how different cancer drugs can trigger a process called apoptosis, which is a way for cells to die in a controlled manner.
- Research indicates that the ability of cancer cells to undergo apoptosis may influence the effectiveness of chemotherapy.
- Certain genes, like bcl-2, can affect whether a cell survives or dies when exposed to chemotherapy.
Takeaway
This study looks at how cancer drugs can make cells die, which is important for treating cancer. Some cells are better at dying than others when treated with these drugs.
Limitations
The biochemistry of apoptosis is not fully understood, and measuring apoptotic cells in tumors is challenging.
Want to read the original?
Access the complete publication on the publisher's website